Chairman Michael J. Farrell - 25 Nov 2024 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Executive Officer
Signature
Michael J. Farrell, Chief Executive Officer
Issuer symbol
RMD
Transactions as of
25 Nov 2024
Net transactions value
+$7,745,134
Form type
4
Filing time
27 Nov 2024, 15:19:42 UTC
Previous filing
12 Nov 2024
Next filing
03 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Gift $0 -2,000 -49% $0.000000 2,090 27 Nov 2024 Lisette and Michael Farrell Family Trust F1
transaction RMD ResMed Common Stock Gift $0 +2,000 $0.000000 2,000 27 Nov 2024 Lisette and Michael Farrell Foundation F2
transaction RMD ResMed Common Stock Sale $499,330 -2,000 -100% $249.66 0 27 Nov 2024 Lisette and Michael Farrell Foundation
holding RMD ResMed Common Stock 455,472 25 Nov 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Award $8,244,464 +33,036 $249.56 33,036 25 Nov 2024 ResMed Common Stock 33,036 $249.56 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Gift of shares transferred to The Lisette and Michael Farrell Family Foundation, Mr. Farrell retains dispositive power over remaining shares.
F2 Gift of shares transferred from The Lisette and Michael Farrell Family Trust, Mr. Farrell retains dispositive power over the gifted shares.
F3 Represents date options first become exercisable. Options vest 1/3 per year.